503162 — Reliance Chemotex Industries Balance Sheet
0.000.00%
- IN₹1.38bn
- IN₹3.82bn
- IN₹3.59bn
- 30
- 36
- 41
- 25
Annual balance sheet for Reliance Chemotex Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 328 | 576 | 613 | 504 | 191 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 251 | 262 | 354 | 479 | 192 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,061 | 1,309 | 1,461 | 1,563 | 1,531 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,474 | 1,890 | 2,324 | 3,158 | 3,103 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,626 | 3,332 | 3,970 | 4,810 | 4,744 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,025 | 1,367 | 1,654 | 1,639 | 1,680 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,583 | 2,118 | 2,650 | 3,474 | 3,371 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1,044 | 1,214 | 1,320 | 1,336 | 1,373 |
Total Liabilities & Shareholders' Equity | 2,626 | 3,332 | 3,970 | 4,810 | 4,744 |
Total Common Shares Outstanding |